Search - tctmd.com

Displaying 1 - 20 of 25

Sort: Relevancy | Date

News Opinion Editor's Corner AHA 2025

What’s Going to Be Hot at AHA 2025?

Michael O'Riordan

November 05, 2025

News Conference News AHA 2024

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

Shelley Wood

November 14, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2024

Shelley Wood

October 01, 2024

News Opinion CV Team Dispatch

September 2024 Dispatch for the CV Team

L.A. McKeown

September 01, 2024

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

L.A. McKeown

June 01, 2024

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

L.A. McKeown

May 01, 2024

News Conference News ACC 2024

TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP

L.A. McKeown

April 16, 2024

News Daily News

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

L.A. McKeown

August 23, 2023

News Daily News

As Renal Denervation Heads to Advisory Review, FDA Sets Out Key Questions

L.A. McKeown

August 18, 2023

News Opinion Editor's Corner ESC 2023

What’s Going to Be Hot at ESC 2023?

Shelley Wood

August 15, 2023

News Daily News

BP Reduction With Renal Denervation Still Evident a Decade On

Michael O'Riordan

January 31, 2023

News Conference News ACC 2021

Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO

Michael O'Riordan

May 16, 2021

News Conference News HFSA 2020

Splanchnic Nerve Ablation Improves HFpEF Symptoms, QoL in FIH Study

L.A. McKeown

October 12, 2020

News Conference News STS 2020

PE for Surgeons: Be Active Participants in Team-Based Care, Experts Urge

Yael L. Maxwell

February 03, 2020

News Daily News

‘People Are Pretty Optimistic’ as Renal Denervation’s Comeback Continues

Todd Neale

June 24, 2019

News Conference News EuroPCR 2019

Small Study Lends Further Support to the Antiarrhythmic Potential of Renal Denervation

L.A. McKeown

June 06, 2019

News Daily News

Renal Denervation Lowers BP in Sham-Controlled Studies: Meta-Analysis

Michael O'Riordan

April 02, 2019

News Daily News

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Michael O'Riordan

December 06, 2018

News Conference News TCT 2018

RADIOSOUND-HTN Suggests Ultrasound May Be Best for Renal Denervation

Todd Neale

September 26, 2018

News Conference News EuroPCR 2018

Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension

Michael O'Riordan

May 23, 2018

Advertisement

What’s Going to Be Hot at AHA 2025?

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

TCTMD’s Top 10 Most Popular Stories for September 2024

September 2024 Dispatch for the CV Team

June 2024 Dispatch for the CV Team

May 2024 Dispatch for the CV Team

TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

As Renal Denervation Heads to Advisory Review, FDA Sets Out Key Questions

What’s Going to Be Hot at ESC 2023?

BP Reduction With Renal Denervation Still Evident a Decade On

Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO

Splanchnic Nerve Ablation Improves HFpEF Symptoms, QoL in FIH Study

PE for Surgeons: Be Active Participants in Team-Based Care, Experts Urge

‘People Are Pretty Optimistic’ as Renal Denervation’s Comeback Continues

Small Study Lends Further Support to the Antiarrhythmic Potential of Renal Denervation

Renal Denervation Lowers BP in Sham-Controlled Studies: Meta-Analysis

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

RADIOSOUND-HTN Suggests Ultrasound May Be Best for Renal Denervation

Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content